What is the initial CHA2DS2-VASc (Congestive heart failure, Hypertension, Age ≥ 75, Diabetes, Stroke or transient ischemic attack, Vascular disease, Age 65-74, Sex category) score for a 73-year-old male with new onset atrial fibrillation (AFib) and no known medical history?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The initial CHA2DS2-VASc score for a 73-year-old male with new onset atrial fibrillation and no known medical history is 2 points. This score is calculated by assigning 1 point for the patient's age being between 65-74 years and 1 point for being male (sex category) 1. Since the patient has no other documented medical conditions such as heart failure, hypertension, diabetes, prior stroke/TIA, or vascular disease, no additional points are added.

Key Considerations

  • A CHA2DS2-VASc score of 2 in a male patient with AFib generally warrants consideration for oral anticoagulation therapy to reduce stroke risk 1.
  • The most commonly used options include direct oral anticoagulants (DOACs) such as apixaban, rivaroxaban, dabigatran, or edoxaban, or warfarin with a target INR of 2-3.
  • The choice between these medications should be individualized based on renal function, bleeding risk, cost considerations, and patient preference 1.
  • It's essential to note that this score helps guide anticoagulation decisions, as patients with AFib have an increased risk of stroke due to blood stasis in the left atrial appendage leading to thrombus formation and potential embolization 1.

Clinical Decision Making

  • The selection of an anticoagulant agent should be based on shared decision-making that takes into account risk factors, cost, tolerability, patient preference, potential for drug interactions, and other clinical characteristics 1.
  • When compared with the CHA2DS2 score, the CHA2DS2-VASc score for AF has a broader score range (0 to 9) and includes a larger number of risk factors (female sex, 65–74 y of age, and vascular disease) 1.

From the Research

CHA2DS2-VASc Score Calculation

To calculate the CHA2DS2-VASc score for a 73-year-old male with new onset atrial fibrillation (AFib) and no known medical history, we need to consider the following factors:

  • Congestive heart failure: 0 points (no known medical history)
  • Hypertension: 0 points (no known medical history)
  • Age ≥ 75: 0 points (patient is 73 years old)
  • Diabetes: 0 points (no known medical history)
  • Stroke or transient ischemic attack: 0 points (no known medical history)
  • Vascular disease: 0 points (no known medical history)
  • Age 65-74: 1 point (patient is 73 years old)
  • Sex category: 0 points (male)

Score Calculation

Based on the above factors, the CHA2DS2-VASc score for this patient would be:

  • 0 (Congestive heart failure) + 0 (Hypertension) + 0 (Age ≥ 75) + 0 (Diabetes) + 0 (Stroke or transient ischemic attack) + 0 (Vascular disease) + 1 (Age 65-74) + 0 (Sex category) = 1

Interpretation

According to the studies 2, 3, 4, 5, 6, a CHA2DS2-VASc score of 1 indicates a relatively low risk of stroke. However, the decision to anticoagulate should be individualized based on the patient's overall risk profile and other factors, such as bleeding risk.

Key Points

  • The CHA2DS2-VASc score is a useful tool for assessing stroke risk in patients with atrial fibrillation.
  • A score of 1 indicates a relatively low risk of stroke, but anticoagulation may still be considered in some cases.
  • The decision to anticoagulate should be individualized based on the patient's overall risk profile and other factors, such as bleeding risk, as noted in studies 2, 3, 4, 5, 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.